MICHAEL COLE MORGAN, O.D.
Optometry at Ruffin Rd, San Diego, CA

2014005, Feb 20, 2014

Sep 21, 2011

13/825601

Robert M. Jones - San Diego CA, US
Juerg Lehmann - San Diego CA, US
Weichao Chen - San Diego CA, US
Jeffrey Edwards - San Diego CA, US
Glen Marquez - San Jose CA, US
Michael E. Morgan - San Diego CA, US
Abu J.M. Sadeque - San Diego CA, US
Sun Hee Kim - San Diego CA, US

ARENA PHARMACEUTICALS, INC. - San Diego CA

C07D 413/14, A61K 45/06, A61K 31/506

514 65, 544328, 514256

The present invention relates to the GPR119 receptor agonists: 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)-N,N-dimethylbenzamide; -fluoro-4-(5-fluoro-6-(4-(3-(2-fluoro-propan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)-N-methylbenzamide; and 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)benzamide, and pharmaceutically acceptable salts, solvates, and hydrates thereof, that are useful as a single pharmaceutical agent or in combination with one or more additional pharmaceutical agents, such as, a DPP-IV inhibitor, a biguanide, an alpha-glucosidase inhibitor, an insulin analogue, a sulfonylurea, an SGLT2 inhibitor, a meglitinide, a thiazolidinedione, or an anti-diabetic peptide analogue, in the treatment of for example, a disorder selected from: a GPR119-receptor-related disorder; a condition ameliorated by increasing secretion of an incretin; a condition ameliorated by increasing a blood incretin level; a condition characterized by low bone mass; a neurological disorder; a metabolic-related disorder; type 2 diabetes; obesity; and complications related thereto.

2009005, Feb 26, 2009

Sep 28, 2006

11/992806

Rajesh K. Agarwal - San Diego CA, US
Rampurna Prasad Gullapalli - San Bruno CA, US
Michael Martin - Carlsbad CA, US
Michael Morgan - San Diego CA, US
Dennis Chapman - San Deigo CA, US
Joseph Belier Speer - Ramona CA, US
Yun Shan - San Diego CA, US

A61K 31/415, A61K 9/48

424456, 514406

The present invention relates to certain pharmaceutical compositions of a 5-HTserotonin receptor modulator and methods for preparing pharmaceutical composition related thereto. The pharmaceutical compositions are useful in the treatment of platelet aggregation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, reducing the risk of blood clot formation, asthma or symptoms thereof, agitation or a symptom, behavioral disorders, drug induced psychosis, excitative psychosis, Gilles de la Tourette's syndrome, manic disorder, organic or NOS psychosis, psychotic disorder, psychosis, acute schizophrenia, chronic schizophrenia, NOS schizophrenia and related disorders, sleep disorders, diabetic-related disorders, progressive multifocal leukoencephalopathy and the like.

2008026, Oct 23, 2008

May 1, 2007

11/743133

C. Gresham Bayne - San Diego CA, US
Gresham B. Bayne - San Diego CA, US
Michael Morgan - San Diego CA, US
Richard L. Oglesby - La Mesa CA, US
James H. Collins - San Diego CA, US

G06Q 50/00

705 2

A patient management system and method are provided. The method of patient management may include receiving appointment data regarding an appointment for a patient with a selected clinician at a predetermined time, inserting an appointment entry on an electronic calendar of the selected clinician, attaching patient data to the appointment entry on the electronic calendar, providing a first electronic link on the appointment entry to medical records of the patient, providing a second electronic link on the appointment entry to a map showing an address of the patient, partially pre-filling a patient visit form using the attached patient data, receiving patient visit data electronically entered by the selected clinician on the patient visit form during the appointment, and storing the patient visit data into a patient database.

2008026, Oct 23, 2008

May 1, 2007

11/743131

C. Gresham Bayne - San Diego CA, US
Gresham B. Bayne - San Diego CA, US
Michael Morgan - San Diego CA, US
James H. Collins - San Diego CA, US

G06Q 50/00, G06F 19/00

705 3, 705 2, 707 10

A patient management system and method are provided. The patient management system may include portable computers for the clinicians making house calls, a centralized database for storing patient medical records, and an office system for communicating with the portable computer to provide the clinician with patient medical information by accessing the database and receive patient visit medical information from the physician. The operating system may also update the database with the patient visit information House calls may be made to single family/person residences, congregate care facilities or communities, and others.

2013031, Nov 28, 2013

Aug 31, 2011

13/820107

Zezhi Jesse Shao - San Diego CA, US
Anthony C. Blackburn - San Diego CA, US
Andrew J. Grottick - Chula Vista CA, US
Michael Morgan - San Diego CA, US
Jaimie Karyn Rueter - San Diego CA, US
Anna Shifrina - San Diego CA, US
Scott Stirn - San Diego CA, US
Libo Yang - San Diego CA, US
Woo Hyun Yoon - San Diego CA, US

A61K 9/28, A61K 45/06, A61K 31/55

424468, 540594, 51421701

The present invention relates to methods for weight management that utilize modified-release dosage forms comprising (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine salts and crystalline forms thereof. The present invention further relates to (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine salts, crystalline forms thereof and modified-release dosage forms comprising them.